Randomized conversion from cyclosporine to tacrolimus in renal transplant patients:: Improved lipid profile and unchanged plasma homocysteine levels

被引：12
|
作者：
Artz, MA
Boots, JMM
Ligtenberg, G
Roodnat, JI
Christiaans, MHL
Hené, RJ
Blom, HJ
Demacker, PNM
Hilbrands, LB
机构：
[1] Univ Nijmegen Hosp, Dept Nephrol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Hosp Maastricht, Dept Nephrol, Maastricht, Netherlands
[3] Univ Utrecht Hosp, Dept Nephrol, Utrecht, Netherlands
[4] Univ Rotterdam Hosp, Dept Nephrol, Rotterdam, Netherlands
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(02)03080-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1793 / 1794
页数：2
相关论文
共 50 条
  • [1] Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus
    Artz, MA
    Boots, JMM
    Ligtenberg, G
    Roodnat, JI
    Christiaans, MHL
    Vos, PF
    Blom, HJ
    Sweep, FCGJ
    Demacker, PNM
    Hilbrands, LB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : 1880 - 1888
  • [2] Plasma homocysteine levels in renal transplant patients on tacrolimus therapy
    Akbas, SH
    Tuncer, M
    Gurkan, A
    Yucetin, L
    Yavuz, A
    Demirbas, A
    Ersoy, F
    Gultekin, M
    Yakupoglu, G
    Akaydin, M
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (01) : 159 - 160
  • [3] Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients
    Colak, T
    Karakayali, H
    Yagmurdur, MC
    Moray, G
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2081 - 2082
  • [4] Effect of conversion from cyclosporine to tacrolimus on cardiovascular risk profile in renal transplant recipients
    Do, Wonseok
    Kwon, Eugene
    Kim, Geun-Hee
    Lee, Kyung Hee
    Kim, Kyu Yeun
    Kim, Minjung
    Yang, Youngae
    Yim, Taehoon
    Hwang, Inryang
    Lee, Sukyung
    Jung, Hee-Yeon
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Chan-Duck
    TRANSPLANTATION, 2016, 100 (07) : S691 - S691
  • [5] Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile
    Woodside, KJ
    Nichols, SD
    Hunter, GC
    Gugliuzza, KK
    Daller, JA
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1877 - 1879
  • [6] Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients
    Baid-Agrawal, S
    Delmonico, FL
    Tolkoff-Rubin, NE
    Farrell, M
    Williams, WW
    Shih, V
    Auchincloss, H
    Cosimi, AB
    Pascual, M
    TRANSPLANTATION, 2004, 77 (08) : 1199 - 1202
  • [7] Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients
    Pohanka, E
    Margreiter, R
    Sparacino, V
    Sperschneider, H
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1874 - 1876
  • [8] Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy:: effect of treatment with folic acid
    Fernández-Miranda, C
    Gómez, P
    Díaz-Rubio, P
    Estenoz, J
    Carrillo, JL
    Andrés, A
    Morales, JM
    CLINICAL TRANSPLANTATION, 2000, 14 (02) : 110 - 114
  • [9] No differences in plasma homocysteine (Hcy) levels between cyclosporine (CsA)- or tacrolimus (TAC)- treated renal transplant recipients (RTR)
    Bae, J
    Tolkoff-Rubin, NE
    Baid, S
    Ovuworie, CA
    Williams, WW
    Shih, VE
    Cosimi, AB
    Pascual, MA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 372A - 372A
  • [10] Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia
    Kohnle, M
    Lütkes, P
    Zimmermann, U
    Philipp, T
    Heemann, U
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (7A) : 44S - 45S
12345